Hualan Biological Engineering Inc. (SHE:002007)

SHE:002007 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	4,518	4,366	5,333	4,503	4,426	5,016
Other Revenue	6.54	13.58	8.9	13.67	10.31	7.09
Revenue	4,525	4,379	5,342	4,517	4,436	5,023
Revenue Growth (YoY)	-16.35%	-18.02%	18.26%	1.82%	-11.69%	35.76%
Cost of Revenue	1,800	1,768	1,727	1,699	1,538	1,405
Gross Profit	2,725	2,611	3,615	2,818	2,898	3,618
Selling, General & Admin	1,062	1,066	1,465	1,205	1,011	1,328
Research & Development	349.87	333.18	280.84	314.7	253.63	213.21
Other Operating Expenses	41.24	38.35	44.62	41.75	36.17	37.29
Operating Expenses	1,455	1,432	1,805	1,595	1,312	1,621
Operating Income	1,270	1,179	1,810	1,223	1,586	1,997
Interest Expense	-10.23	-12.95	-13.17	-30.27	-21.72	-4.97
Interest & Investment Income	156.7	157.95	164.47	128.92	85.28	100.8
Currency Exchange Gain (Loss)	-0.17	-0.15	-0.3	-0.01	0.33	0.3
Other Non Operating Income (Expenses)	-20.78	-0.49	-0.28	-0.38	-0.34	-0.44
EBT Excluding Unusual Items	1,395	1,323	1,961	1,322	1,650	2,093
Gain (Loss) on Sale of Investments	26.09	32.94	60.54	36.11	26.86	25.96
Gain (Loss) on Sale of Assets	-0.8	0.08	44.44	47.67	0.42	-0.26
Asset Writedown	8.6	-5.71	-9.71	-1.19	-3.23	-0.62
Other Unusual Items	-13.18	-11.81	21.24	24.17	14.39	29.33
Pretax Income	1,416	1,339	2,078	1,428	1,688	2,147
Income Tax Expense	186.75	183.14	315.96	180.76	234.13	303.21
Earnings From Continuing Operations	1,229	1,155	1,762	1,248	1,454	1,844
Minority Interest in Earnings	-65.87	-67.62	-280.11	-171.34	-155.22	-231.06
Net Income	1,164	1,088	1,482	1,076	1,299	1,613
Net Income to Common	1,164	1,088	1,482	1,076	1,299	1,613
Net Income Growth	-16.60%	-26.57%	37.66%	-17.14%	-19.48%	25.69%
Shares Outstanding (Basic)	1,824	1,826	1,824	1,825	1,821	1,818
Shares Outstanding (Diluted)	1,826	1,829	1,824	1,828	1,831	1,820
Shares Change (YoY)	-0.19%	0.23%	-0.19%	-0.17%	0.59%	0.13%
EPS (Basic)	0.64	0.60	0.81	0.59	0.71	0.89
EPS (Diluted)	0.64	0.59	0.81	0.59	0.71	0.89
EPS Growth	-16.44%	-26.75%	37.92%	-17.00%	-19.95%	25.52%
Free Cash Flow	861.29	803.92	592.43	563.36	621.15	703.85
Free Cash Flow Per Share	0.47	0.44	0.33	0.31	0.34	0.39
Dividend Per Share	0.200	0.200	0.300	0.300	0.200	0.300
Dividend Growth	-33.33%	-33.33%	-	50.00%	-33.33%	-2.50%
Gross Margin	60.22%	59.62%	67.67%	62.38%	65.33%	72.03%
Operating Margin	28.07%	26.92%	33.89%	27.08%	35.76%	39.76%
Profit Margin	25.71%	24.84%	27.73%	23.83%	29.28%	32.11%
Free Cash Flow Margin	19.04%	18.36%	11.09%	12.47%	14.00%	14.01%
EBITDA	1,539	1,439	2,069	1,496	1,783	2,179
EBITDA Margin	34.01%	32.86%	38.74%	33.12%	40.18%	43.38%
D&A For EBITDA	268.96	260.07	259.05	272.5	196.39	181.66
EBIT	1,270	1,179	1,810	1,223	1,586	1,997
EBIT Margin	28.07%	26.92%	33.89%	27.08%	35.76%	39.76%
Effective Tax Rate	13.19%	13.68%	15.21%	12.65%	13.87%	14.12%
Revenue as Reported	4,525	4,379	5,342	4,517	4,436	5,023
Advertising Expenses	-	5.08	6.31	2.84	3.38	2.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.